The TARGET-HBV study engages an observational research design to conduct a comprehensive review of outcomes for patients with CHB infection. The initial phase of the study that enrolled patients treated with tenofovir alafenamide (TAF) was successfully completed. The current protocol (Amendment 1) describes the second phase of the study that will engage research activities for patients being managed for CHB in usual clinical practice in the US and Canada. The study addresses important clinical questions regarding the management of CHB by collecting and analyzing data from patients at academic and community medical centers. TARGET-HBV creates a robust database of real-world data regarding the natural history, management, and health outcomes related to antiviral treatments used in clinical practice.
Hepatitis B, Hepatitis, Liver Diseases
The TARGET-HBV study engages an observational research design to conduct a comprehensive review of outcomes for patients with CHB infection. The initial phase of the study that enrolled patients treated with tenofovir alafenamide (TAF) was successfully completed. The current protocol (Amendment 1) describes the second phase of the study that will engage research activities for patients being managed for CHB in usual clinical practice in the US and Canada. The study addresses important clinical questions regarding the management of CHB by collecting and analyzing data from patients at academic and community medical centers. TARGET-HBV creates a robust database of real-world data regarding the natural history, management, and health outcomes related to antiviral treatments used in clinical practice.
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
-
Banner University Medical Center Phoenix, Phoenix, Arizona, United States, 85006
Asian Pacific Liver Center at Coalition of Inclusive Medicine, Los Angeles, California, United States, 90020
California Liver Research Institute, Pasadena, California, United States, 91105
Stanford University, Redwood City, California, United States, 94063
UC Davis GI/Hepatology Clinical Trials Unit, Sacramento, California, United States, 95817
Silicon Valley Research Institute, San Jose, California, United States, 95128
Yale University Digestive Diseases, New Haven, Connecticut, United States, 06520
Medstar Georgetown University Hospital, Washington, District of Columbia, United States, 20007
University of Florida, Gainesville, Florida, United States, 32610-0272
University of Miami, Schiff Center for Liver Disease, Miami, Florida, United States, 33136
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Target PharmaSolutions, Inc.,
2026-01